Sabra Health Care REIT Statistics
Total Valuation
SBRA has a market cap or net worth of $3.16 billion. The enterprise value is $5.53 billion.
Market Cap | 3.16B |
Enterprise Value | 5.53B |
Important Dates
The next confirmed earnings date is Wednesday, May 8, 2024, after market close.
Earnings Date | May 8, 2024 |
Ex-Dividend Date | Feb 12, 2024 |
Share Statistics
SBRA has 231.48 million shares outstanding. The number of shares has increased by 0.80% in one year.
Shares Outstanding | 231.48M |
Shares Change (YoY) | +0.80% |
Shares Change (QoQ) | +2.75% |
Owned by Insiders (%) | 1.23% |
Owned by Institutions (%) | 94.38% |
Float | 228.10M |
Valuation Ratios
The trailing PE ratio is 227.50 and the forward PE ratio is 23.02. SBRA's PEG ratio is 3.15.
PE Ratio | 227.50 |
Forward PE | 23.02 |
PS Ratio | 4.88 |
Forward PS | 4.76 |
PB Ratio | 1.13 |
P/FCF Ratio | 8.21 |
PEG Ratio | 3.15 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.73, with an EV/FCF ratio of 14.36.
EV / Earnings | 401.79 |
EV / Sales | 8.54 |
EV / EBITDA | 17.73 |
EV / EBIT | 42.94 |
EV / FCF | 14.36 |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.86 |
Debt / EBITDA | 7.74 |
Debt / FCF | 6.27 |
Interest Coverage | 1.14 |
Financial Efficiency
Return on equity (ROE) is 0.50% and return on invested capital (ROIC) is 3.47%.
Return on Equity (ROE) | 0.50% |
Return on Assets (ROA) | 0.30% |
Return on Capital (ROIC) | 3.47% |
Revenue Per Employee | $13.49M |
Profits Per Employee | $286,583 |
Employee Count | 48 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, SBRA has paid $2.00 million in taxes.
Income Tax | 2.00M |
Effective Tax Rate | 12.70% |
Stock Price Statistics
The stock price has increased by +25.34% in the last 52 weeks. The beta is 1.17, so SBRA's price volatility has been higher than the market average.
Beta (1Y) | 1.17 |
52-Week Price Change | +25.34% |
50-Day Moving Average | 14.04 |
200-Day Moving Average | 13.69 |
Relative Strength Index (RSI) | 41.40 |
Average Volume (30 Days) | 2,098,998 |
Short Selling Information
The latest short interest is 11.34 million, so 4.90% of the outstanding shares have been sold short.
Short Interest | 11.34M |
Short Previous Month | 11.19M |
Short % of Shares Out | 4.90% |
Short % of Float | 4.97% |
Short Ratio (days to cover) | 5.51 |
Income Statement
In the last 12 months, SBRA had revenue of $647.51 million and earned $13.76 million in profits. Earnings per share was $0.06.
Revenue | 647.51M |
Gross Profit | 647.51M |
Operating Income | 207.19M |
Pretax Income | 15.76M |
Net Income | 13.76M |
EBITDA | 311.81M |
EBIT | 128.72M |
Earnings Per Share (EPS) | $0.06 |
Balance Sheet
The company has $46.72 million in cash and $2.41 billion in debt, giving a net cash position of -$2.37 billion or -$10.23 per share.
Cash & Cash Equivalents | 46.72M |
Total Debt | 2.41B |
Net Cash | -2.37B |
Net Cash Per Share | -$10.23 |
Equity / Book Value | 2.80B |
Book Value Per Share | 12.11 |
Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was $300.57 million and capital expenditures $84.24 million, giving a free cash flow of $384.81 million.
Operating Cash Flow | 300.57M |
Capital Expenditures | 84.24M |
Free Cash Flow | 384.81M |
FCF Per Share | $1.66 |
Margins
Gross margin is 100.00%, with operating and profit margins of 32.00% and 2.12%.
Gross Margin | 100.00% |
Operating Margin | 32.00% |
Pretax Margin | 2.43% |
Profit Margin | 2.12% |
EBITDA Margin | 48.15% |
EBIT Margin | 19.88% |
FCF Margin | 59.43% |
Dividends & Yields
This stock pays an annual dividend of $1.20, which amounts to a dividend yield of 8.79%.
Dividend Per Share | $1.20 |
Dividend Yield | 8.79% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 2,000.00% |
Buyback Yield | -0.80% |
Shareholder Yield | 7.99% |
Earnings Yield | 0.44% |
FCF Yield | 12.18% |
Analyst Forecast
The average price target for SBRA is $15.45, which is 13.19% higher than the current price. The consensus rating is "Buy".
Price Target | $15.45 |
Price Target Difference | 13.19% |
Analyst Consensus | Buy |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | 6.51% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 16, 2010. It was a reverse split with a ratio of 1:3.
Last Split Date | Nov 16, 2010 |
Split Type | Reverse |
Split Ratio | 1:3 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |